LUNGevity releases Lung Cancer Scorecard that grades individual states on policies that support access to optimal care for lung cancer patients.

How does your state rank?

Today, LUNGevity was joined by policymakers, healthcare providers, patients/survivors, and other members of our community at a briefing on Capitol Hill to discuss the results of our year-long study grading states on their response to lung cancer. We are proud to share our findings with the release of the Lung Cancer Scorecard, which you can download at LungCancerScore.org.

We are committed to increasing patient access to optimal care because it is essential to ensuring the best possible outcome – survivorship. LUNGevity undertook the state-by-state study, comparing access to screening, comprehensive biomarker testing, and access to clinical trials, to uncover disparities in lung cancer patient care based on location and to offer viable solutions to achieve healthcare equity.

The Lung Cancer Scorecard clearly illustrates the disparities in access to healthcare in the U.S., and LUNGevity recognizes there is a lot of work to do. The Scorecard establishes a baseline to measure improvements (or lack thereof) in how lung cancer care is delivered, and to identify pain points and opportunities in the system that we can address to improve patient access to precision medicine treatments. We are excited to see the great advances we can make with the roadmap laid by this report.

Find out how your state ranked, and more about our Lung Cancer Scorecard, on our website. Interested in learning more about lung cancer advocacy? Sign up for policy updates.